Antibacterial synergy of glycerol monolaurate and aminoglycosides in Staphylococcus aureus biofilms

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 11, 2014, Pages 6970-6973

  Hess, Donavon J ^a,b   Henry Stanley, Michelle J ^a   Wells, Carol L ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; GENTAMICIN; GLYCEROL DERIVATIVE; GLYCEROL MONOLAURATE; LAURIC ACID DERIVATIVE; STREPTOMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN; AMINOGLYCOSIDE; AMPICILLIN; ANTIINFECTIVE AGENT; MONOACYLGLYCEROL; MONOLAURIN; SURFACTANT;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOFILM; COLONY FORMING UNIT; DRUG EFFECT; DRUG POTENTIATION; MICROBIAL COMMUNITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; COMBINATION DRUG THERAPY; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; STAPHYLOCOCCAL INFECTIONS;

AMINOGLYCOSIDES; AMPICILLIN; ANTI-BACTERIAL AGENTS; BIOFILMS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; GENTAMICINS; LAURATES; MICROBIAL SENSITIVITY TESTS; MONOGLYCERIDES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOMYCIN; SURFACE-ACTIVE AGENTS; VANCOMYCIN;

EID: 84908397835     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03672-14     Document Type: Article

References (26)

1. Code of Federal Regulations. 2010. Title 21. Food and drugs. Chapter I. Food and Drug Administration. Subchapter B. Food for human consumption. Part 184. Direct food substances affirmed as generally recognized as safe. Subpart B. Listing of specific substances affirmed as GRAS. 21 CFR 184.1505 - mono- and diglycerides. http://cfr.vlex.com/vid/184-1505-mono-and-diglycerides-19707498.
2. Thormar H, Isaacs CE, Brown HR, Barshatzky MR, Pessolano T. 1987. Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides. Antimicrob. Agents Chemother. 31:27-31. http://dx.doi.org/10.1128/AAC.31.1.27.
3. Schlievert PM, Deringer JR, Kim MH, Projan SJ, Novick RP. 1992. Effect of glycerol monolaurate on bacterial growth and toxin production. Antimicrob. Agents Chemother. 36:626-631. http://dx.doi.org/10.1128/AAC.36.3.626.
4. Schlievert PM, Peterson ML. 2012. Glycerol monolaurate antibacterial activity in broth and biofilm cultures. PLoS One 7(7):e40350. http://dx.doi.org/10.1371/journal.pone.0040350.
5. Fux CA, Costerton JW, Stewart PS, Stoodley P. 2005. Survival strategies of infectious biofilms. Trends Microbiol. 13:34-40. http://dx.doi.org/10.1016/j.tim.2004.11.010.
6. Hall-Stoodley L, Stoodley P. 2009. Evolving concepts in biofilm infections. Cell. Microbiol. 11:1034-1043. http://dx.doi.org/10.1111/j.1462-5822.2009.01323.x.
7. Bjarnsholt T. 2013. The role of bacterial biofilms in chronic infections. APMIS Suppl. 1-51. http://dx.doi.org/10.1111/apm.12099.
8. Flemming H-C, Neu TR, Wozniak DJ. 2007. The EPS matrix: the "house of biofilm cells." J. Bacteriol. 189:7945-7947. http://dx.doi.org/10.1128/JB.00858-07.
9. Flemming H-C, Wingender J. 2010. The biofilm matrix. Nat. Rev. Microbiol. 8:623-633. http://dx.doi.org/10.1038/nrmicro2415.
10. Cos P, Tote K, Horemans T, Maes L. 2010. Biofilms: an extra hurdle for effective antimicrobial therapy. Curr. Pharm. Des. 16:2279-2295. http://dx.doi.org/10.2174/138161210791792868.
11. Fux CA, Wilson S, Stoodley P. 2004. Detachment characteristics and oxacillin resistance of Staphylococcus aureus biofilm emboli in an in vitro catheter infection model. J. Bacteriol. 186:4486-4491. http://dx.doi.org/10.1128/JB.186.14.4486-4491.2004.
12. Shanks RMQ, Donegan NP, Graber ML, Buckingham SE, Zegans ME, Cheung AL, O'Toole GA. 2005. Heparin stimulates Staphylococcus aureus biofilm formation. Infect. Immun. 73:4596-4606. http://dx.doi.org/10.1128/IAI.73.8.4596-4606.2005.
13. Wells CL, Henry-Stanley MJ, Barnes AMT, Dunny GM, Hess DJ. 2011. Relationship between antibiotic susceptibility and ultrastructure of Staphylococcus aureus biofilms on surgical suture. Surg. Infect. 12:297-305. http://dx.doi.org/10.1089/sur.2010.104.
14. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing; approved standard M100-S16, 16th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
15. Erlandsen SL, Kristich CJ, Dunny GM, Wells CL. 2004. High-resolution visualization of the microbial glycocalyx with low-voltage scanning electron microscopy: dependence on cationic dyes. J. Histochem. Cytochem. 52:1427-1435. http://dx.doi.org/10.1369/jhc.4A6428.2004.
16. Hess DJ, Henry-Stanley MJ, Wells CL. 2011. Gentamicin promotes Staphylococcus aureus biofilms on silk suture. J. Surg. Res. 170:302-308. http://dx.doi.org/10.1016/j.jss.2011.06.011.
17. Ruzin A, Novick RP. 2000. Equivalence of lauric acid and glycerol monolaurate as inhibitors of signal transduction in Staphylococcus aureus. J. Bacteriol. 182:2668-2671. http://dx.doi.org/10.1128/JB.182.9.2668-2671.2000.
18. Noll KS, Prichard MN, Khaykin A, Sinko PJ, Chikindas ML. 2012. The natural antimicrobial peptide subtilosin acts synergistically with glycerol monolaurate, lauric arginate, and ε-poly-L-lysine against bacterial vaginosis-associated pathogens but not human lactobacilli. Antimicrob. Agents Chemother. 56:1756-1761. http://dx.doi.org/10.1128/AAC.05861-11.
19. Pechous R, Ledala N, Wilkinson BJ, Jayaswal RK. 2004. Regulation of the expression of cell wall stress stimulon member gene msrA1 in methicillin-susceptible or -resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 48:3057-3063. http://dx.doi.org/10.1128/AAC.48.8.3057-3063.2004.
20. Hess DJ, Henry-Stanley MJ, Barnes MT, Dunny GM, Wells CL. 2012. Ultrastructure of a novel bacterial form located in Staphylococcus aureus in vitro and in vivo catheter-associated biofilms. J. Histochem. Cytochem. 60:770-776. http://dx.doi.org/10.1369/0022155412457573.
21. Quinn GA, Maloy AP, Banat MM, Banat IM. 2013. A comparison of effects of broad-spectrum antibiotics and biosurfactants on established bacterial biofilms. Curr. Microbiol. 67:614-623. http://dx.doi.org/10.1007/s00284-013-0412-8.
22. Daddi Oubekka S, Briandet R, Fontaine-Aupart MP, Steenkeste K. 2012. Correlative time-resolved fluorescence microscopy to assess antibiotic diffusion-reaction in biofilms. Antimicrob. Agents Chemother. 56:3349-3358. http://dx.doi.org/10.1128/AAC.00216-12.
23. Rani SA, Pitts B, Stewart PS. 2005. Rapid diffusion of fluorescent tracers into Staphylococcus epidermidis biofilms visualized by time lapse microscopy. Antimicrob. Agents Chemother. 49:728-732. http://dx.doi.org/10.1128/AAC.49.2.728-732.2005.
24. Anderl JN, Zahller J, Roe F, Stewart PS. 2003. Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob. Agents Chemother. 47:1251-1256. http://dx.doi.org/10.1128/AAC.47.4.1251-1256.2003.
25. Holland KT, Taylor D, Farrell AM. 1994. The effect of glycerol monolaurate on growth of, and production of toxic shock syndrome toxin-1 and lipase by, Staphylococcus aureus. J. Antimicrob. Chemother. 33:41-55. http://dx.doi.org/10.1093/jac/33.1.41.
26. Schlievert PM, Merriman JA, Salgado-Pabon W, Mueller EA, Spaulding AR, Vu BG, Chang-Smith O, Kohler PL, Kirby JR. 2013. Menaquinone analogs inhibit growth of bacterial pathogens. Antimicrob. Agents Chemother. 57:5432-5437. http://dx.doi.org/10.1128/AAC.01279-13.